Skip to main content
. 2021 Apr 6;320(6):L1085–L1092. doi: 10.1152/ajplung.00046.2021

Table 1.

Airspace biomarkers of pneumococcal pneumonia-related lung injury in models 1) without and 2) with antibiotics

Studies without Antibiotics
Ligand Control (n = 12) WRW4 (n = 13) *Ratio Uncorrected P Value
IL-1β 725 (581–947) 566 (495–709) 0.78 0.016
TNF-α 6,983 (4,907–8,480) 5,517 (3,493–6,020) 0.79 0.044
CXCL9 2,749 (1,854–3,840) 1,197 (875–1,929) 0.44 0.011
IFN-γ 165 (123–214) 95 (80–121) 0.58 0.002
IL-2 56 (53–62) 54 (48–57) 0.96 0.039
CXCL10 11,182 (8,963–13,928) 4,126 (896–5,166) 0.37 0.0002
MIP-1α 61,246 (54,135–73,161) 58,037 (24,421–73,015) 0.95 0.201
GM-CSF 259 (139–309) 201 (142–265) 0.78 0.503
IL-17 71 (49–135) 70 (51–92) 0.99 0.583
IL-6 6,404 (4,032–7,839) 4,922 (4,385–8,150) 0.77 0.878
IL-1α 873 (766–1,194) 673 (487–995) 0.77 0.070
MCP-1 1,089 (802–1,574) 851 (349–1,335) 0.78 0.096
KC 7,236 (6,269–8,079) 7,378 (7,162–7,929) 1.02 0.650
Studies with Antibiotics
Ligand CTX (n = 8) CTX + WRW4 (n = 10) *Ratio Uncorrected P Value
TNF-α 149 (114–241) 95 (78–167) 0.64 0.046
IL-1β 80 (68–97) 74 (56–110) 0.93 0.760
CXCL9 820 (444–1,011) 967 (354–1,528) 1.18 0.377
IL-2 28 (27–31) 29 (27–32) 1.04 0.852
CXCL10 554 (290–897) 598 (330–1,026) 1.08 0.566
MIP-1α 323 (200–498) 314 (221–406) 0.97 0.915
IL-17 0.63 (0.35–0.93) 0.44 (0.28–0.81) 0.70 0.369
IL-6 232 (130–326) 240 (123–733) 1.03 0.633
IL-1α 72 (49–94) 54 (46–96) 0.75 0.617
MCP-1 976 (639–1551) 1,011 (733–1,206) 1.04 0.948
KC 213 (147–338) 202 (123–309) 0.95 0.662
IFN-γ Too low to measure
GM-CSF Too low to measure

Median (IQR) values at 24 h (above) or 72h (below) postinfection are expressed in pg/mL. *Ratio of the ligand in 1) WRW4 to control and 2) CTX + WRW4 to CTX only. CTX, ceftriaxone; CXCL, C-X-C ligand; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; IQR, interquartile range; KC, murine homolog of IL-8; MCP, monocyte chemoattractant protein; MIP, macrophage inflammatory protein; TNF, tumor necrosis factor.